Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc.
| Actelion Pharmaceuticals Ltd. and Actelion Pharmaceuticals US, Inc. |
| Mylan Pharmaceuticals Inc. |
| 1:2023cv00088 |
| November 7, 2023 |
| US District Court for the Northern District of West Virginia |
| Thomas S Kleeh |
| Patent - Abbreviated New Drug Applications (ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 16, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 14
ORDER APPROVING APPLICATIONS TO APPEAR PRO HAC VICE [ECF NOS. #7 , #8 , #9 , #10 , #11 ]. Preston K. Ratliff II, Bruce M. Wexler, Mi Zhou, Jessica Stauring and Mark Russell Sperling are admitted to appear pro hac vice in this matter. Signed by Chief District Judge Thomas S Kleeh on 11/16/2023. (jb)
|
| Filing 13 Pro Hac Vice filing fee in the amount of $200.00 paid for Mark Russell Sperling. Receipt number 100003763. (jb) |
| Filing 12 Pro Hac Vice filing fee in the amount of $800 paid for Preston K. Ratliff, II, Bruce M. Wexler, Mi Zhou, and Jessica Stauring. Receipt Number 100003762. (jb) |
| Filing 11 MOTION for Leave to Appear Pro Hac Vice of Mark Russell Sperling by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: #1 Proposed Order)(Taylor, Chad) |
| Filing 10 MOTION for Leave to Appear Pro Hac Vice of Jessica Stauring by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: #1 Proposed Order)(Taylor, Chad) |
| Filing 9 MOTION for Leave to Appear Pro Hac Vice of Mi Zhou by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: #1 Proposed Order)(Taylor, Chad) |
| Filing 8 MOTION for Leave to Appear Pro Hac Vice of Bruce M. Wexler by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: #1 Proposed Order)(Taylor, Chad) |
| Filing 7 MOTION for Leave to Appear Pro Hac Vice of Preston K. Ratliff, II by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc.. (Attachments: #1 Proposed Order)(Taylor, Chad) |
| Filing 6 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (mas) |
| Filing 5 VERIFICATION OF ATTORNEY ADMISSION has been sent to attorneys Wexler, Ratliff, Zhou, Sperling and Stauring. (mas) |
| Filing 3 Corporate Disclosure Statement by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc. identifying Corporate Parent Johnson & Johnson for Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc. (mas) |
| Filing 2 "Wrong event used, refiled as DE #6 ". Modified on 11/8/2023 (mas). (Main Document 2 replaced on 11/8/2023) (mas). |
| Filing 1 COMPLAINT against Mylan Pharmaceuticals Inc. filed by Actelion Pharmaceuticals Ltd., Actelion Pharmaceuticals US, Inc. (Attachments: #1 Exhibit A-781 patent, #2 Exhibit B-015 Patent, #3 Civil Cover Sheet) Filing Fee $402. Receipt #AWVNDC-3822056. (mas) Modified on 11/8/2023 to identify Exhibits (mas). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
